Slowing FAP progression: Tafamidis meglumine is a small molecule capable of stabilizing the transthyretin (TTR) tetramer. Tafamidis acts in a similar way to the natural hormone T4, prevents TTR amyloid fibril formation, and offers a potential alternative to liver transplantation for the treatment of patients with TTR familial amyloid polyneuropathies (TTR-FAP).

Tafamidis (Vyndaqel): A Light for FAP Patients

NENCETTI, SUSANNA;ROSSELLO, ARMANDO;ORLANDINI, ELISABETTA
2013

Abstract

Slowing FAP progression: Tafamidis meglumine is a small molecule capable of stabilizing the transthyretin (TTR) tetramer. Tafamidis acts in a similar way to the natural hormone T4, prevents TTR amyloid fibril formation, and offers a potential alternative to liver transplantation for the treatment of patients with TTR familial amyloid polyneuropathies (TTR-FAP).
Nencetti, Susanna; Rossello, Armando; Orlandini, Elisabetta
File in questo prodotto:
File Dimensione Formato  
1617_ftp.pdf

non disponibili

Tipologia: Abstract
Licenza: Importato da Ugov Ricerca - Accesso privato/ristretto
Dimensione 336.48 kB
Formato Adobe PDF
336.48 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/244951
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 18
social impact